FY 2024 and FY 2025 Labor, Health and Human Services and Education appropriations bill
FY 2024 and FY 2025 Defense appropriations bill, issues related to malaria, infectious disease, public health research and development
FY 2024 and FY 2025 State and Foreign operations appropriations bill, issues related to malaria and global health programs
FY 2024 and FY 2025 funding for global health research and development
Provisions related to CDC, NIH, USAID funding for global health, antimicrobial resistance programs, pandemic preparedness and vaccines
FY 2025 budget request for global health programs and research and development
Senate Malaria and National Tropical Diseases (NTD) Caucus
SIGHT ACT (H.R. 6424)
Recognition of World Neglected Tropical Disease Day
Recognition of World Malaria Day
Duration: January 18, 2022
to
present
General Issues: Budget/Appropriations , Medical/Disease Research/Clinical Labs , Foreign Relations , Defense
Spending: about $360,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2022: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), White House Office, Office of Science & Technology Policy (OSTP), State - Dept of (DOS), U.S. Agency for International Development (USAID), Office of Management & Budget (OMB), Centers For Disease Control & Prevention (CDC)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Venable LLP lobbied for American Society of Tropical Medicine and Hygiene , earning $40,000. The report was filed on April 22.
Original Filing: 301572959.xml
Lobbying Issues
FY 2024 and FY 2025 Labor, Health and Human Services and Education appropriations bill
FY 2024 and FY 2025 Defense appropriations bill, issues related to malaria, infectious disease, public health research and development
FY 2024 and FY 2025 State and Foreign operations appropriations bill, issues related to malaria and global health programs
FY 2024 and FY 2025 funding for global health research and development
Provisions related to CDC, NIH, USAID funding for global health, antimicrobial resistance programs, pandemic preparedness and vaccines
FY 2025 budget request for global health programs and research and development
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Senate Malaria and National Tropical Diseases (NTD) Caucus
SIGHT ACT (H.R. 6424)
Recognition of World Neglected Tropical Disease Day
Recognition of World Malaria Day
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2023
In Q4, Venable LLP lobbied for American Society of Tropical Medicine and Hygiene , earning $40,000. The report was filed on Jan. 20.
Original Filing: 301533825.xml
Lobbying Issues
FY 2024 Labor, Health and Human Services and Education appropriations bill
FY 2024 Defense appropriations bill, issues related to malaria, infectious disease, public health research and development
FY 2024 State and Foreign operations appropriations bill, issues related to malaria and global health programs
FY 2024 funding for global health research and development
Provisions related to CDC, NIH, USAID funding for global health antimicrobial resistance programs, pandemic preparedness and vaccines
FY 2025 budget request for global health programs and research and development
Lobbying Issues
Senate Malaria and National Tropical Diseases (NTD) Caucus
SIGHT ACT (H.R. 6424)
Public Health Week Resolution (H.R. 78)
National Institutes of Health (NIH) subgrantee policy
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Natl Institutes of Health (NIH) White House Office Office of Science & Technology Policy (OSTP)
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2023
In Q3, Venable LLP lobbied for American Society of Tropical Medicine and Hygiene , earning $40,000. The report was filed on Oct. 18, 2023.
Original Filing: 301503566.xml
Lobbying Issues
FY 2024 Labor, Health and Human Services and Education appropriations bill; FY 2024 Defense appropriations bill, issues related to malaria, infectious disease, public health research and development; FY 2024 State and Foreign operations appropriations bill, issues related to malaria and global health programs; FY 2024 funding for global health research and development; Provisions related to CDC, NIH, USAID funding for global health antimicrobial resistance programs, pandemic preparedness and vaccines; FY 2025 budget request for global health programs and research and development
Lobbying Issues
PASTEUR Act; Reauthorization of Pandemic and all Hazards Preparedness Act; SMASH Act
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2023
In Q2, Venable LLP lobbied for American Society of Tropical Medicine and Hygiene , earning $40,000. The report was filed on July 20, 2023.
Original Filing: 301486938.xml
Lobbying Issues
FY 2025 Labor, Health and Human Services and Education appropriations bill; FY 2024 Defense appropriations bill, issues related to malaria, infectious disease, public health research and development; FY 2025 State and Foreign operations appropriations bill, issues related to malaria and global health programs; FY 2024 funding for global health research and development; Provisions related to CDC, NIH, USAID funding for global health antimicrobial resistance programs, pandemic preparedness and vaccines
Lobbying Issues
PASTEUR Act; World Malaria Day Resolution; Reauthorization of Pandemic and all Hazards Preparedness Act; NIH Director Confirmation
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2023
In Q1, Venable LLP lobbied for American Society of Tropical Medicine and Hygiene , earning $40,000. The report was filed on April 20, 2023.
Original Filing: 301463619.xml
Lobbying Issues
FY 2024 Labor, Health and Human Services and Education appropriations bill; FY 2024 Defense appropriations bill, issues related to malaria, infectious disease, public health research and development; FY 2024 State and Foreign operations appropriations bill, issues related to malaria and global health programs; FY 2024 funding for global health research and development; Provisions related to CDC, NIH, USAID funding for global health antimicrobial resistance programs, pandemic preparedness and vaccines; supplemental appropriations for global COVID-19 programs and monkeypox programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
PASTEUR Act; World Malaria Day Resolution
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
DOD malaria research funding
4th Quarter, 2022
In Q4, Venable LLP lobbied for American Society of Tropical Medicine and Hygiene , earning $40,000. The report was filed on Jan. 19, 2023.
Original Filing: 301435765.xml
Lobbying Issues
FY 2023 Labor, Health and Human Services and Education appropriations bill; FY 2023 Defense appropriations bill, issues related to malaria, infectious disease, public health research, and development; FY 2023 State and Foreign operations appropriations bill, issues related to malaria and global health programs; FY 2023 funding for global health research and development; Provisions related to CDC, NIH, USAID funding for global health, antimicrobial resistance programs, pandemic preparedness and vaccines; supplemental appropriations for global Covid-19 programs and monkeypox programs; FY 2024 funding for global health research and programs.
Lobbying Issues
Public Health Programs for Infectious and Tropical Disease; Pandemic preparedness; S. 3799 PREVENT Pandemics Act; S. 5354 One Health Security Act.
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Global Health Research and Development.
Lobbying Issues
DOD malaria research funding
3rd Quarter, 2022
In Q3, Venable LLP lobbied for American Society of Tropical Medicine and Hygiene , earning $40,000. The report was filed on Oct. 19, 2022.
Original Filing: 301410213.xml
Lobbying Issues
FY 2023 Labor, Health and Human Services and Education appropriations bill; FY 2023 Defense appropriations bill, issues related to malaria, infectious disease, public health research, and development; FY 2023 State and Foreign operations appropriations bill, issues related to malaria and global health programs; FY 2023 funding for global health research and development; Provisions related to CDC, NIH, USAID funding for global health, antimicrobial resistance programs, pandemic preparedness and vaccines; supplemental appropriations for global Covid-19 programs and monkeypox programs; FY 2024 funding for global health research and programs.
Agencies Lobbied
White House Office Health & Human Services - Dept of (HHS) U.S. Agency for International Development (USAID) Office of Management & Budget (OMB)
Lobbying Issues
Public Health Programs for Infectious and Tropical Disease; Pandemic preparedness; S. 3799 PREVENT Pandemics Act; H.R. 3932/S. 2076 PASTEUR Act of 2021.
Agencies Lobbied
U.S. Agency for International Development (USAID)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Global Health Research and Development.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
DOD malaria research funding
2nd Quarter, 2022
In Q2, Venable LLP lobbied for American Society of Tropical Medicine and Hygiene , earning $40,000. The report was filed on July 20, 2022.
Original Filing: 301388907.xml
Lobbying Issues
FY 2023 Labor, Health and Human Services and Education appropriations bill; FY 2023 Defense appropriations bill, issues related to malaria, infectious disease, public health research, and development; FY 2023 State and Foreign operations appropriations bill, issues related to malaria and global health programs; FY 2023 funding for global health research and development; Provisions related to CDC, NIH, USAID funding for global health, pandemic preparedness and vaccines; supplemental appropriations for global Covid-19 programs.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Public Health Programs for Infectious and Tropical Disease; Pandemic preparedness; S. 3799 PREVENT Pandemics Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Global Health Research and Development.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
DOD malaria research funding
1st Quarter, 2022
In Q1, Venable LLP lobbied for American Society of Tropical Medicine and Hygiene , earning $40,000. The report was filed on April 20, 2022.
Original Filing: 301369801.xml
Lobbying Issues
FY 2022 Labor, Health and Human Services and Education appropriations bill; FY 2022 Defense appropriations bill, issues related to malaria, infectious disease, public health research, and development; FY 2022 State and Foreign operations appropriations bill, issues related to malaria and global health programs; FY 2022 and FY 2023 funding for global health research and development; Provisions related to CDC, NIH, USAID funding for global health, pandemic preparedness and vaccines; supplemental appropriations for global Covid-19 programs.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Public Health Programs for Infectious and Tropical Disease; Pandemic preparedness; S. 3799 PREVENT Pandemics Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Global Health Research and Development.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
DOD malaria research funding
1st Quarter, 2022
Venable LLP filed a lobbying registration on March 28, 2022 to represent American Society of Tropical Medicine and Hygiene, effective Jan. 18, 2022.
Original Filing: 301343042.xml
Issue(s) they said they’d lobby about: Global health research and development appropriations and programs .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate